The National Institutes of Health has awarded $3.8 million to Texas Biomedical Research Institute to further develop a promising HIV vaccine candidate that stops the virus upon entry, before it begins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback